gracielle
Registered
- Joined
- Jun 6, 2005
- Messages
- 3,659
- Likes
- 3,010
Click anywhere on the article in Spanish to open the menu. Next click on Translate to English.
25 January 2024
From transmission to symptoms: 7 keys to the JN.1 subvariant of COVID....Globally, JN.1 is currently the most circulating subvariant of interest and has been reported by 71 countries, as reported by the World Health Organization (WHO). It has been detected in Colombia, Argentina, Mexico, and Peru, among other Latin American countries....
JN.1 appears to be highly contagious, perhaps more so than any other member of the Omicron family, said William Schaffner, a professor of infectious diseases and health policy at Vanderbilt University School of Medicine....Consulted by Infobae, Dr. Humberto Debat, virology researcher at Conicet and the National Institute of Agricultural Technology , commented: “The JN.1 subvariant is the one that is becoming predominant in the world. It is related to the chronology of infections, the immunological status of the population and a low frequency of application of booster doses of vaccines. This facilitates the possibility of new infections.”
As reported by the Ministry of Health of the Nation in Argentina, on January 17, 2 confirmed cases of the BA.2.86 subvariant (with residence in the province of Santa Cruz) and 6 cases of the JN.1 subvariant were detected. Two of these patients reside in the City of Buenos Aires, 1 in Chaco, 1 in Salta, 1 in Santa Cruz and 1 case in Santa Fe...
What are the symptoms of subvariant JN.1....They may include fever or chills, cough, feeling short of breath, fatigue, muscle and body aches, headache, new loss of smell or taste, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea. COVID symptoms can last 1 to 4 weeks, but in some cases, recovery can take up to 12 weeks. If symptoms last more than 12 weeks, long COVID may have developed. Wear a mask. “From the day the COVID symptoms begin, affected people should isolate themselves for 5 days so as not to transmit the pathogen to other people,” said Javier Farina , doctor and member of the Argentine Society of Infectious Diseases (SADI) in dialogue with Infobae....
25 January 2024
De transmisión a síntomas: 7 claves sobre la subvariante JN.1 del COVID
La OMS informó que esta variante ya fue detectada en pacientes de 71 países. Los detalles sobre sus particularidades y cuánto tiempo hay que aislarse para no contagiar
www.infobae.com
JN.1 appears to be highly contagious, perhaps more so than any other member of the Omicron family, said William Schaffner, a professor of infectious diseases and health policy at Vanderbilt University School of Medicine....Consulted by Infobae, Dr. Humberto Debat, virology researcher at Conicet and the National Institute of Agricultural Technology , commented: “The JN.1 subvariant is the one that is becoming predominant in the world. It is related to the chronology of infections, the immunological status of the population and a low frequency of application of booster doses of vaccines. This facilitates the possibility of new infections.”
As reported by the Ministry of Health of the Nation in Argentina, on January 17, 2 confirmed cases of the BA.2.86 subvariant (with residence in the province of Santa Cruz) and 6 cases of the JN.1 subvariant were detected. Two of these patients reside in the City of Buenos Aires, 1 in Chaco, 1 in Salta, 1 in Santa Cruz and 1 case in Santa Fe...
What are the symptoms of subvariant JN.1....They may include fever or chills, cough, feeling short of breath, fatigue, muscle and body aches, headache, new loss of smell or taste, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea. COVID symptoms can last 1 to 4 weeks, but in some cases, recovery can take up to 12 weeks. If symptoms last more than 12 weeks, long COVID may have developed. Wear a mask. “From the day the COVID symptoms begin, affected people should isolate themselves for 5 days so as not to transmit the pathogen to other people,” said Javier Farina , doctor and member of the Argentine Society of Infectious Diseases (SADI) in dialogue with Infobae....
Last edited: